Literature DB >> 26432701

Biochemical insights from population studies with genetics and metabolomics.

Karsten Suhre1, Johannes Raffler2, Gabi Kastenmüller3.   

Abstract

Genome-wide association studies with concentrations of hundreds of small molecules in samples collected from thousands of individuals (mGWAS) access otherwise inaccessible natural genetic experiments and their influence on the metabolic capacities of the human body. By sampling the natural metabolic and genetic variability that is present in the general population, mGWAS identified over 150 associations between genetic variants and variation in the metabolic composition of human body fluids. Many of these genetic variants were found to be located in enzyme or transporter coding genes, whose functions match the biochemical nature of the associated metabolites. Associations identified by mGWAS can reveal novel biochemical knowledge, such as the function of uncharacterized genes, the biochemical identity of small molecules, and the structure of entire biochemical pathways. Here we review findings of recent mGWAS and discuss concrete examples of how their results can be interpreted in a biochemical context. We describe online resources that are available for mining mGWAS results. In this context, we present two concepts that also find more general applications in the field of metabolomics: strengthening of associations by looking at ratios between metabolite pairs and reconstruction of metabolic pathways by Gaussian graphical modeling.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetic variation; Genome-wide association study; Metabolic individuality; Metabolomics; Partial correlation

Mesh:

Year:  2015        PMID: 26432701     DOI: 10.1016/j.abb.2015.09.023

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  21 in total

1.  Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.

Authors:  Tove Fall; Samira Salihovic; Stefan Brandmaier; Christoph Nowak; Andrea Ganna; Stefan Gustafsson; Corey D Broeckling; Jessica E Prenni; Gabi Kastenmüller; Annette Peters; Patrik K Magnusson; Rui Wang-Sattler; Vilmantas Giedraitis; Christian Berne; Christian Gieger; Nancy L Pedersen; Erik Ingelsson; Lars Lind
Journal:  Diabetologia       Date:  2016-07-12       Impact factor: 10.122

2.  Whole-genome sequencing study of serum peptide levels: the Atherosclerosis Risk in Communities study.

Authors:  Paul S de Vries; Bing Yu; Elena V Feofanova; Ginger A Metcalf; Michael R Brown; Atefeh L Zeighami; Xiaoming Liu; Donna M Muzny; Richard A Gibbs; Eric Boerwinkle; Alanna C Morrison
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

Review 3.  Metabolomic Biomarkers in the Progression to Type 1 Diabetes.

Authors:  Anne Julie Overgaard; Simranjeet Kaur; Flemming Pociot
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

Review 4.  Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.

Authors:  Stephen Burgess; Eric Harshfield
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-04       Impact factor: 3.243

5.  Natural and Synthetic Neurotoxins in Our Environment: From Alzheimer's Disease (AD) to Autism Spectrum Disorder (ASD).

Authors:  Aileen I Pogue; Walter J Lukiw
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-07-26

Review 6.  Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.

Authors:  Abdellah Tebani; Carlos Afonso; Stéphane Marret; Soumeya Bekri
Journal:  Int J Mol Sci       Date:  2016-09-14       Impact factor: 5.923

Review 7.  Translational Bioinformatics: Past, Present, and Future.

Authors:  Jessica D Tenenbaum
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-02-11       Impact factor: 7.691

8.  Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge?

Authors:  Mika Ala-Korpela; George Davey Smith
Journal:  Int J Epidemiol       Date:  2016-10-27       Impact factor: 7.196

9.  Metabolomics enables precision medicine: "A White Paper, Community Perspective".

Authors:  Richard D Beger; Warwick Dunn; Michael A Schmidt; Steven S Gross; Jennifer A Kirwan; Marta Cascante; Lorraine Brennan; David S Wishart; Matej Oresic; Thomas Hankemeier; David I Broadhurst; Andrew N Lane; Karsten Suhre; Gabi Kastenmüller; Susan J Sumner; Ines Thiele; Oliver Fiehn; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2016-09-02       Impact factor: 4.290

10.  Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.

Authors:  James W Baurley; Christopher K Edlund; Carissa I Pardamean; David V Conti; Ruth Krasnow; Harold S Javitz; Hyman Hops; Gary E Swan; Neal L Benowitz; Andrew W Bergen
Journal:  Nicotine Tob Res       Date:  2016-04-25       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.